Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pelvic Neoplasms × Vorinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 16 Leukemia, Myeloid, Acute 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Breast Neoplasms 14 Multiple Myeloma 12 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma, Non-Hodgkin 10 Carcinoma, Non-Small-Cell Lung 10 Leukemia 9 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Lymphoma, Mantle-Cell 8 Lymphoma, Follicular 8 Neuroblastoma 7 Neoplasm Metastasis 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Brain Neoplasms 7 Recurrence 6 Neoplasms, Plasma Cell 6 Lymphoma, B-Cell, Marginal Zone 6 Lung Neoplasms 6 Pancreatic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, Large-Cell, Anaplastic 5 Immunoblastic Lymphadenopathy 5 Glioblastoma 5 Burkitt Lymphoma 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Radiotherapy 4 Surveys and Questionnaires 3 Specimen Handling 2 Iohexol 2 spartalizumab 1 sodium thiosulfate 1 X-Rays 1 Watchful Waiting 1 Vorinostat 1 Surgical Procedures, Operative 1 Sunitinib 1 Solutions 1 Saline Solution 1 Re-Irradiation 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Probiotics 1 Platinum 1 Particle Accelerators 1 Pafolacianine 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Lidocaine 1 Ketamine 1 Injections 1 Immunotherapy, Adoptive 1 Hyperthermic Intraperitoneal Chemotherapy 1 FS 069 1 Exercise Test 1 Embolization, Therapeutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455351 2023-05-08

PRAVO

Oslo University Hospital

Phase 1 Completed

Pelvic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡